Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Prospective Multi-center Single-arm Target Value Clinical Trial for Evaluating Clinical Use Safety and Efficacy of the Firehorus Vertebral Artery Rapamycin-target-eluting Stent System

NCT02328781 is registered in ClinicalTrials.gov with Zhongrong Miao as lead sponsor.

NCT NCT02328781
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT02328781 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Prospective Multi-center Single-arm Target Value Clinical Trial for Evaluating Clinical Use Safety and Efficacy of the Firehorus Vertebral Artery Rapamycin-target-eluting Stent System
Lead sponsor
Zhongrong Miao
Phase
Not applicable
Overall status
Completed
Start date
July 17, 2014
Completion date
November 25, 2016
Enrollment
101 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

vertebrobasilar insufficiency